Investors might be interested in how sell-side analysts are viewing shares of G1 THERAPEUTICS (:GTHX). Taking a peek at the current consensus rating, we can see that the ABR is 1. This average rating is provided by Zacks Research. This simplified scale ranges from one to five which translates brokerage firm Buy/Sell/Hold recommendations into an average broker rating. A low number in the 1-2 range typically indicates a Buy, 3 represents a Hold and 4-5 indicates a consensus Sell rating. In terms of the number of analysts that have the stock pegged as a Buy or Strong Buy, we note that the number is presently 5.

Investors hope that they won’t have to deal with stock picks that don’t pan out, but this happens quite often in the stock market. At some point, the investor may have to make the tough decision to sell a stock that previously had a lot of upward potential. Holding onto an underperforming stock can sometimes hurt the portfolio. Investors may be hesitant to let go of the stock long after it should have been sold. Tracking the underlying fundamentals can assist the investor with figuring out the proper time to buy or sell a particular stock. Mastering this aspect of investing may come with experience, but it may be highly beneficial for the long-term success of the portfolio.

Shifting gears, we can see that the current quarter EPS consensus estimate for G1 THERAPEUTICS (:GTHX) is -0.97. This EPS estimate is using 5 sell-side analysts polled by Zacks Research. For the prior reporting period, the company posted a quarterly EPS of -0.86. As we move through earnings season, all eyes will be on the company to see if they can beat analyst estimates and show improvement from the last quarter. When a company reports actual earnings numbers, the surprise factor can cause a stock price to realize increased activity. Investors and analysts will be closely watching to see how the earnings results impact the stock after the next release. Many investors will decide to be cautious around earnings releases and delay buy/sell moves until after the stock price has steadied.

Viewing some popular support and resistance marks on shares of G1 THERAPEUTICS (:GTHX), we can see that the 52-week high is presently $40.58, and the 52-week low is currently $14.4. When the stock is trading near the 52-week high or 52-week low, investors may be on the lookout for a potential break through the level. Looking at recent action, we can see that the stock has been trading near the $22.9 level. Investors may also want to track historical price activity. Over the past 12 weeks, the stock has changed -42.42%. Looking further back to the beginning of the calendar year, we note that shares have moved 19.58%. Over the previous 4 weeks, shares have seen a change of -2.47%. Over the last 5 trading sessions, the stock has moved 6.02%. Investors will be monitoring stock activity over the next few days to try and gauge which way the momentum is shifting.

Wall Street analysts tracking shares of G1 THERAPEUTICS (:GTHX) have been closely monitor company activities and fundamentals. They often create research reports to assist with investment decisions. On a consensus basis, analysts have set a target price of $61.25 on the stock. This number may be different from the First Call consensus target estimate. Analysts that routinely cover the company may use different techniques in order to create a future target price. Because of the different methods, price targets may differ greatly from one analyst to another.

Investors may be drawing up a plan for the stretch run of the calendar year. With stocks riding high, the plan may involve looking at some different classes of shares. If the portfolio is full of large caps, investors may be looking for some small cap growth stocks to add to the mix. Investors may also be looking into purchasing some foreign stocks to get the portfolio as diversified as possible. Investors may also choose to select shares from various industries. Comparing stocks among peers can be a useful way to decide which ones might be ahead of the curve and poised for an upward move.